Follow the 진양제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 진양제약 has recorded 17 insider filings. Market capitalisation: €53.4bn. The latest transaction was filed on 18 May 2026 (Sale). Among the most active insiders: 진양제약. The full history is free.
17
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
2 ops.
Sell Volume
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,103 of 28,199 companies
72.8
score / 100
Value
73
Quality
72
FCF yld-4.0%
Earn yld40%
EV/EBITDA4.0x
ROE16%
Gross mgn65%
Net mgn18%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Jinyang Pharmaceutical is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the research and development of medications.